251 related articles for article (PubMed ID: 17938253)
41. CD28 costimulation is required not only to induce IL-12 receptor but also to render janus kinases/STAT4 responsive to IL-12 stimulation in TCR-triggered T cells.
Park WR; Park CS; Tomura M; Ahn HJ; Nakahira Y; Iwasaki M; Gao P; Abe R; Hamaoka T; Fujiwara H
Eur J Immunol; 2001 May; 31(5):1456-64. PubMed ID: 11465102
[TBL] [Abstract][Full Text] [Related]
42. CD28 is not required for c-Jun N-terminal kinase activation in T cells.
Rivas FV; O'Herrin S; Gajewski TF
J Immunol; 2001 Sep; 167(6):3123-8. PubMed ID: 11544297
[TBL] [Abstract][Full Text] [Related]
43. T cell activation up-regulates the expression of the focal adhesion kinase Pyk2: opposing roles for the activation of protein kinase C and the increase in intracellular Ca2+.
Tsuchida M; Manthei ER; Alam T; Knechtle SJ; Hamawy MM
J Immunol; 1999 Dec; 163(12):6640-50. PubMed ID: 10586059
[TBL] [Abstract][Full Text] [Related]
44. Regulation and interaction of pp90(rsk) isoforms with mitogen-activated protein kinases.
Zhao Y; Bjorbaek C; Moller DE
J Biol Chem; 1996 Nov; 271(47):29773-9. PubMed ID: 8939914
[TBL] [Abstract][Full Text] [Related]
45. Targeted knock-in mice expressing mutations of CD28 reveal an essential pathway for costimulation.
Dodson LF; Boomer JS; Deppong CM; Shah DD; Sim J; Bricker TL; Russell JH; Green JM
Mol Cell Biol; 2009 Jul; 29(13):3710-21. PubMed ID: 19398586
[TBL] [Abstract][Full Text] [Related]
46. Anticancer agent pristimerin inhibits IL-2 induced activation of T lymphocytes.
Liu Y; Gao X; Deeb D; Zhang Y; Shaw J; Gautam SC
J Exp Ther Oncol; 2016 Jul; 11(3):181-188. PubMed ID: 28471123
[TBL] [Abstract][Full Text] [Related]
47. Activation of peripheral CD8+ T lymphocytes via CD28 plus CD2: evidence for IL-2 gene transcription mediated by CD28 activation.
Carabasi MH; DiSanto JP; Yang SY; Dupont B
Tissue Antigens; 1991 Jan; 37(1):26-32. PubMed ID: 1676547
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of the MEK/ERK signaling pathway blocks a subset of B cell responses to antigen.
Richards JD; Davé SH; Chou CH; Mamchak AA; DeFranco AL
J Immunol; 2001 Mar; 166(6):3855-64. PubMed ID: 11238629
[TBL] [Abstract][Full Text] [Related]
49. Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity.
Roux PP; Richards SA; Blenis J
Mol Cell Biol; 2003 Jul; 23(14):4796-804. PubMed ID: 12832467
[TBL] [Abstract][Full Text] [Related]
50. Lysophosphatidylserine suppresses IL-2 production in CD4 T cells through LPS
Shinjo Y; Makide K; Satoh K; Fukami F; Inoue A; Kano K; Otani Y; Ohwada T; Aoki J
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):332-338. PubMed ID: 29017923
[TBL] [Abstract][Full Text] [Related]
51. Role of TNF receptor-associated factor 2 and p38 mitogen-activated protein kinase activation during 4-1BB-dependent immune response.
Cannons JL; Choi Y; Watts TH
J Immunol; 2000 Dec; 165(11):6193-204. PubMed ID: 11086053
[TBL] [Abstract][Full Text] [Related]
52. ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15.
Vaidyanathan H; Opoku-Ansah J; Pastorino S; Renganathan H; Matter ML; Ramos JW
Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19837-42. PubMed ID: 18077417
[TBL] [Abstract][Full Text] [Related]
53. Opposing roles of serine/threonine kinases MEKK1 and LOK in regulating the CD28 responsive element in T-cells.
Tao L; Wadsworth S; Mercer J; Mueller C; Lynn K; Siekierka J; August A
Biochem J; 2002 Apr; 363(Pt 1):175-82. PubMed ID: 11903060
[TBL] [Abstract][Full Text] [Related]
54. Inhibitory role for dual specificity phosphatase VHR in T cell antigen receptor and CD28-induced Erk and Jnk activation.
Alonso A; Saxena M; Williams S; Mustelin T
J Biol Chem; 2001 Feb; 276(7):4766-71. PubMed ID: 11085983
[TBL] [Abstract][Full Text] [Related]
55. The p38 mitogen-activated protein kinase is activated by ligation of the T or B lymphocyte antigen receptors, Fas or CD40, but suppression of kinase activity does not inhibit apoptosis induced by antigen receptors.
Salmon RA; Foltz IN; Young PR; Schrader JW
J Immunol; 1997 Dec; 159(11):5309-17. PubMed ID: 9548470
[TBL] [Abstract][Full Text] [Related]
56. Farnesyltransferase inhibitors inhibit T-cell cytokine production at the posttranscriptional level.
Marks RE; Ho AW; Robbel C; Kuna T; Berk S; Gajewski TF
Blood; 2007 Sep; 110(6):1982-8. PubMed ID: 17545504
[TBL] [Abstract][Full Text] [Related]
57. CD4-mediated signals induce T cell dysfunction in vivo.
Chirmule N; Avots A; LakshmiTamma SM; Pahwa S; Serfling E
J Immunol; 1999 Jul; 163(2):644-9. PubMed ID: 10395653
[TBL] [Abstract][Full Text] [Related]
58. Enhanced interaction between SEC2 mutant and TCR Vβ induces MHC II-independent activation of T cells via PKCθ/NF-κB and IL-2R/STAT5 signaling pathways.
Fu X; Xu M; Song Y; Li Y; Zhang H; Zhang J; Zhang C
J Biol Chem; 2018 Dec; 293(51):19771-19784. PubMed ID: 30352872
[TBL] [Abstract][Full Text] [Related]
59. Lck is required for activation-induced T cell death after TCR ligation with partial agonists.
Yu XZ; Levin SD; Madrenas J; Anasetti C
J Immunol; 2004 Feb; 172(3):1437-43. PubMed ID: 14734719
[TBL] [Abstract][Full Text] [Related]
60. Two distinct mechanisms of interleukin-2 gene expression in human T lymphocytes.
June CH; Jackson KM; Ledbetter JA; Leiden JM; Lindsten T; Thompson CB
J Autoimmun; 1989 Jun; 2 Suppl():55-65. PubMed ID: 2550020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
